ArticleFrontiers in oncology2022

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma.

Ran Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.